Some U.S. patients taking the two highest doses of Novo Nordisk’s Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine. Wegovy is a…

Read Full Article (External Site)